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In recent decades, the survival of patients with cystic fibro-
sis (CF) has increased significantly, with a current median of 
approximately 38 years in European and North American 
countries.1,2 Currently, almost 50% of CF patients in the 
United States are adults.2 A better approach in the treat-
ment of pulmonary disease and improvement of patients’ 
nutritional status were responsible for these changes. 
In the 80s, Corey et al, comparing two similar groups of 
patients with CF followed in Boston and Toronto, observed 
increased survival in the group from Canada (30 versus 21 
years).3 The better nutritional status of these patients was 
the determining factor for this difference, as the degree of 
pulmonary involvement was comparable in both groups. 
While patients from Toronto received a diet without restric-
tion of fat, the ones from Boston received a low-fat diet 
and, therefore, one with lower caloric intake. It was con-
cluded that although the progressive pulmonary disease is 
the leading cause of mortality in CF, concerns with nutri-
tional guidance and intervention in these patients was 
essential. 
Many studies have suggested that severe pulmonary dis-
ease is consistently correlated with nutritional status dete-
rioration and, on the other hand, prevention of malnutri-
tion is related to a better course of pulmonary disease and 
longer patient survival.4,5 Several authors have shown that 
patients undergoing aggressive nutritional rehabilitation 
through high-calorie diets by gastrostomy or nasogastric 
tube, improved their nutritional status, while pulmonary 
disease was stabilized.6,7 
A national study, evaluating 87 patients with CF aged 
6 months to 18 years and grouping them according to over-
all disease severity measured by the Shwachman score 
(CF severity score) also showed that patients with less pul-
monary involvement had better nutritional status and those 
with increased pulmonary involvement showed poor nutri-
tional status, with significant differences between the 
groups regarding the different anthropometric variables 
assessed. The use of simple measures of nutritional advice 
in the long term allowed attaining greater adherence to 
enzyme supplementation and high-calorie dietary supple-
ments, contributing to nutritional status improvement 
observed in some of these patients.8
Hortencio et al, in an article published in this issue of the 
journal and that evaluated 52 patients with a mean age of 
6 years, whose CF diagnosis was made at a median close to 
two years, found 40.4% of patients with Z BMI / A scores 
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<–2 and 38% with H/A score <–2 at the first visit to the 
referral center, which reflected severe nutritional impair-
ment. With the implementation of therapeutic measures 
– enzyme supplementation, hypercaloric diet and pulmo-
nary disease management – most patients showed nutri-
tional recovery, with a decrease in BMI/A and H/A Z scores 
<–2 to 7.7% (only 4 patients) in both indices. However, as 
the authors emphasize, patients with BMI/A and H/A Z 
scores between –1 and –2 must be considered at nutritional 
risk and this was verified in 23 and 30.8% of patients in this 
study, respectively.
This sentence group of patients must undergo stringent 
monitoring of nutritional status. Some associations between 
better anthropometric indices and lower severity of respi-
ratory disease were observed as fewer hospitalizations, 
later respiratory symptom onset and better results on spi-
rometry. However, the finding of a better H/A index with 
longer time between birth and diagnosis and between the 
first visit and diagnosis was paradoxical, as 90.8% of 
patients were pancreatic insufficient and in this situation, 
one would expect a worsening in this anthropometric index 
with diagnostic delay and thus, at the start of pancreatic 
enzyme supplementation.9
With the implementation of newborn screening for CF in 
the state of São Paulo in February 2010 10 we expect to 
attain an early diagnosis of CF, allowing timely therapeutic 
interventions to be made and attaining benefits such as 
improved growth, nutrition, pulmonary function and prog-
nosis, as observed in countries where newborn screening 
for CF is already a routine.11,12
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